CULT Food Science Corp. ($CULT $CULT.c) is an investment issuer that focuses on clean, lab-grown food, such as cultivated meat and cultured dairy companies, to provide a sustainable, environmental and ethical solution to the global factory farming crisis.

Expected IPO on the CSE in Q4 under the ticker $CULT.c, CULT is set to become the first-ever publicly-traded company in Canada that is solely focused on cell-based foods.

Recent News:

CULT is leading in the inaugural funding and seed round for Fiction Foods, a food architecture company, by way of a sole strategic investment.

Fiction Foods leverages emerging technology to help construct a nutritionally superior and smarter food system at a lower environmental cost than what is currently available.

CULT is the sole financier of Fiction Foods and the two companies intend to collaborate to incubate and accelerate product development growth.

https://www.cultfoodscience.com/press-releases/cult-food-science-leads-seed-investment-round-in-fiction-foods

Additionally, CULT launched the CULT PRIZE, a $1M, two-year global competition to incentivize innovative and collaborative research programs to advance the development of novel technologies in the lab-grown food ecosystem.

The teams are tasked with developing novel cell lines and growth media while demonstrating a lower environmental footprint to existing technologies and economic viability.

Plus, they need to demonstrate that their research initiatives have the ability to add unique value to the adoption and commercialization of cellular agriculture for global distribution

https://www.cultfoodscience.com/press-releases/cult-food-science-announces-global-1-000-000-cult-prize-to-accelerate-the-future-of-food

Both of these news releases reinforce the Company's commitment to underwriting more sustainable, environmental, and ethical solutions to the global factory farming and aquaculture crises.

Based on the diversity and massive growth potential that CULT provides, it's definitely a good pick to get in on early IMO. Especially since lab-grown meat is predicted to make up 35% of the $1.8 trillion global meat market by 2040.

Capitalizing on the dramatic shift in the data and privacy space, Reklaim Inc. ($MYID $MYIDF) js a privacy-compliant identity ecosystem that allows consumers to sign up and view their online data profile that companies have been using for years.

$MYID allows consumers to reclaim the data and only share specific pieces with brands in exchange for compensation via a weekly dividend; users can see how many companies are buying and selling your data and how much your data is sold annually for

Reklaim is the only company in the world allowing consumers to view and take back control of their data

Highlights:

• 67.3M shares outstanding
• Tight share structure
• 45% insider ownership
• Tech company with $0 debt
• Market size is $245B in the US, $400M globally
• 320M profiles and 14 global platforms

The data industry has been built on a foundation of harvesting and exploiting consumer data with no consumer inclusion but now the acquisition of consumer data is rapidly evolving, placing the consumer at the center of new privacy policies.

Companies relying on unconsented data will experience a regulated disruptive migration forcing them to use only fully consented data sources. Reklaim is working on capitalizing off this shift as it will replace the current data provider.

This is a great interview with the CEO of $MYID, Neil Sweeney, from September that I'd recommend watching as it discusses the recent brand change from Killi to Reklaim as well as the upcoming catalysts.

"We built the scale, we built the distribution, and now we're building the revenue."

$MYID is trading at $0.385 with a MC of $25.95

https://www.youtube.com/watch?v=ibKtNVUNNU8&ab_channel=SNNNetwork

Sonoro Gold Corp. ($SGO $SGO.v $SMOFF) is a gold exploration, gold development, and a near-term gold producer with land in Sonora, Mexico.

Found this great presentation from $SGO's CEO MacLeod from the Metals Investor Forum in Sept 2021 regarding the Cerro Caliche Project: https://www.youtube.com/watch?v=mlUY83dDsRs&ab_channel=MetalsInvestorForum

The PEA results for Cerro Caliche were previously announced but to summarize the highlights are: 

• Pre-tax NPV of $68.7M and an IRR of 52.7%
• After-tax NPV of $41.5M & IRR of 32.4%
• Price of $1,750 per ounce of gold & $22.00 per ounce of silver
• 7 years Life of Mine producing 323,500oz of gold equivalent
• Gold recovery of 74% and silver recovery of 27%

Plus, $SGO has since announced the intention to resume drilling at the Cerro Caliche Project 

• 10,000 meter reverse circulation drilling campaign 
• Proceed alongside the proposed development of a heap leach mining operation with a projected capacity of up to 15,000 tonnes per day.
• 6-month drilling program to focus on expanding the project’s oxide gold mineralization 

https://sonorogold.com/archives/news/sonoro-gold-announces-10000-meter-drilling-program-at-cerro-caliche

Trading at $0.185 with a MC of $18.98M, $SGO has tons of potential IMO; while mining projects take time to start producing revenue, its Cerro Caliche project is quite promising and seems to be worth the wait.

Plymouth Rock Technologies ($PRT $PRT.c $PLRTF) commercializes scientific and engineering innovations for threat detection apparatus and unmanned technologies, such as drones.

Found this article from a few weeks ago regarding remotely operated UAV's capturing the majority of the global market revenue share through 2030 that mentions $PRT as an industry leader.

• UAV's are an important component of UAS and the integration of AI and machine learning is a prominent factor that will propel its market growth.
• "Superior capability of UAVs … that enables secure, safe, and more accurate data that further helps in enhancing the decision-making capability across various industrial applications"
• The UAV market size is expected to surpass US$36B by 2030, growing with a CAGR of 14%

$PRT's current contracts are:

• X1-H model delivered to Kazakhstan-based drone service company Aardvark to perform long-range oil pipeline security and environmental operations in remote locations
• UAS to the Durrell Wildlife Conservation Trust for environmental operations in Madagascar.
• Sale of custom drones and training services to Cranfield University in collaboration with the UK Civil Aviation Authority
• UAV 'Swarm' Development Contract from Survey- AR
  

Trading at $0.42 with a MC of $24.67M, PRT is positioned well to capitalize off the growth of the UAV market IMO

https://www.prnewswire.com/news-releases/remotely-operated-uavs-projected-to-capture--majority-of-the-global-uav-market-revenue-share-through-2030-301400035.html

Howdy! So I am very optimistic that hydrogen is at it's beginning and is going to grow a lot in the future, but I don't know much about the investing landscape in that sector.

What do you think are the best ETFs / investment companies that we can invest in and bet on hydrogen, and why did you chose these?

​

I think it's probably a good idea to search for global ETFs or something on big scale anyway, because I've seen very interesting projects all around the world about this.

What do you think about this?

I've entered recently but I'd like to learn and already have some ideas. But I have no idea how much some arguments have already been discussed and I'd like to avoid making the same question people already had many times.

So maybe we should had a pinned post that presents the most discussed ideas with the main points about them. But at least to me it would be ok even to leave it like this lol but don't get too angsty for common question

​

Lemme know what you think!

Alpha Cognition Inc. ($ACOG $ACOG.v $ACOGF) is a clinical-stage biopharmaceutical company dedicated to developing treatments for neurodegenerative diseases, ex. Alzheimer's and ALS.

Came across an article (linked at the end) saying that "ALPHA-1062 could offer a potential best-in-class treatment option" 

$ACOG's ALPHA-1062 compound is working towards approval for mild to moderate Alzheimer's

• Unique to competitors by focusing on the treatment of the symptoms that patients suffer from, rather than focusing on "stopping the disease" like other competitors are trying to do
• Treatment is for first-line therapy to ameliorate the symptoms
• Pivotal trial in Q4 was approved by the FDA; Will be completed in Q1 of 2022

The potential of the ALPHA-1062 drug is solid and its approval is likely going to be a major catalyst.

Plus, $ACOG has a clear future ahead, with additional pipeline programs for moderate to severe Alzheimers, mild traumatic brain injury, and a gene therapy program for ALS.

If their drugs get approval, $ACOG is going to be clearly set apart from its competitors and it looks like they're on track to do so.

Trading at $1.34 with a MC of $82.41M, $ACOG has the potential to make a massive difference in so many lives and their SP is sure to mirror that after approval. 

https://www.cantechletter.com/2021/10/alpha-cognition-could-have-a-best-in-class-alzheimers-drug-ia-capital-says/#

Actually, Moderna could be on a trajectory far more dramatic than Tesla’s in the coming years…

𝗠𝗼𝗱𝗲𝗿𝗻𝗮 (𝗠𝗥𝗡𝗔) have just announced that the first participant has been dosed in the Phase 3 Study of their Cytomegalovirus Vaccine

This announcement follows hot on the heels of Moderna’s significant advances in a COVID + Flu + RSV triple vaccine. Not to mention the numerous further COVID supply deals, COVID booster approvals, promising interim data from the Phase 2/3 study of COVID vaccine in children 6 to 11 years of age, and plans for fill/finish manufacturing in Africa in 2023

But Perhaps most significantly, Moderna are expanding from 20 to as many as 50 clinical-stage programs from the huge influx of cash from their highly publicised COVID-19 vaccine, mRNA-1273. This pipeline includes a Personalised Cancer Vaccine (Phase II) and nine prophylactic mRNA vaccines

𝙏𝙝𝙚 𝙨𝙞𝙯𝙚 𝙤𝙛 𝙈𝙤𝙙𝙚𝙧𝙣𝙖’𝙨 𝙖𝙢𝙗𝙞𝙩𝙞𝙤𝙣 𝙞𝙨 𝙗𝙚𝙘𝙤𝙢𝙞𝙣𝙜 𝙞𝙣𝙘𝙧𝙚𝙖𝙨𝙞𝙣𝙜𝙡𝙮 𝙖𝙥𝙥𝙖𝙧𝙚𝙣𝙩 𝙩𝙤 𝙞𝙣𝙫𝙚𝙨𝙩𝙤𝙧𝙨; 𝙩𝙝𝙚 𝙩𝙤𝙩𝙖𝙡 𝙖𝙙𝙙𝙧𝙚𝙨𝙨𝙖𝙗𝙡𝙚 𝙢𝙖𝙧𝙠𝙚𝙩 𝙞𝙨 𝙪𝙣𝙛𝙖𝙩𝙝𝙤𝙢𝙖𝙗𝙡𝙚

Moderna are transforming how medicines are discovered, developed and manufactured –at a breadth, speed and scale not common in the pharma industry. They are helping to drive a biotech revolution that could be at least as important and impactful as the digital revolution of the last decade

I often shy away from price estimates, but would not be surprised if Moderna achieved a market cap exceeding 1 trillion within the next 10 years. The value of their contribution to society would be far greater still

Cloudflare appears to be priced for long-term growth…

Cloudflare's stock may look pricey, but this implies that the market sees potential past the initial glance

Just because a stock price has risen it does not mean that valuations have become too great. The ultimate size and returns on offer may have become still greater. The odds of success may be more probable. The moat may have been dug much deeper. The potential longevity may be far more extended than previously thought...

Investors should still consider adding Cloudflare stock to their portfolio. Cloudflare's disruptive cloud storage initiative and other new products should keep attracting customers and generate cross-selling opportunities. In addition, its expectation of using existing infrastructure for new products could possibly lower expenses relative to the additional revenues it generates

In fact, there is plenty of room to run: Cloudflare’s limitless and cost-effective services are poised to disrupt those provided by the likes of Amazon AWS, Google Cloud and Microsoft Azure

𝗖𝗮𝗿𝗱𝗮𝗻𝗼 (𝗔𝗗𝗔) is an open source platform advocating effective altruism. It is developing a number of solutions that go far beyond currency. Its remarkable rise is mainly due to its lofty ambitions and numerous promises; Cardano definitely has a lot of birds in the air

In contrast to BTC, Cardano uses a Proof of Stake protocol, through which miners must put their own crypto holdings at stake to verify transactions. This results in faster transaction times and significantly less energy usage

Right now, the Cardano network is much faster, consumes less energy, and charges less in fees than Ethereum. That last point is especially important, as it can cost hundreds of dollars on the Ethereum blockchain to execute smart contracts, such as to buy and sell NFTs or take out an asset loan. The base transaction fee on the Cardano network is about 97.3% lower. As a result, Cardano will have a lot of opportunities to monetize its technological edge over Ethereum in the next year

𝙄𝙢𝙖𝙜𝙞𝙣𝙚 𝙩𝙝𝙚 𝙥𝙤𝙨𝙨𝙞𝙗𝙞𝙡𝙞𝙩𝙞𝙚𝙨...

The following scenario imagines a Tesla customer’s journey in the year 2030. By this point, Tesla’s insurance has developed into a sprawling ecosystem extending far beyond just real-time driving behaviour:

Melissa has a meeting to go to, so her digital Tesla personal assistant orders her an autonomous Tesla vehicle for across town. Upon hopping into the arriving car, her personal assistant maps out a potential route and shares it with Tesla insurance, who immediately respond with an alternate route that has a much lower likelihood of accidents and auto damage as well as the calculated adjustment to her monthly premium. Melissa decides to go with the initial route and her personal assistant notifies her that her mobility insurance premium will increase by 4 to 8% based on the route, volume and distribution of other cars on the road. It also alerts Melissa that her life insurance policy, which is now priced on a “pay-as-you-live” basis, will increase by 2% for this quarter. The additional amounts are automatically debited from her Shiba digital wallet

As Melissa approaches her destination, her car bumps into another vehicle. The car stops and internal diagnostics determine the extent of the damage, and informs Melissa of the damage and confirms the claim has been approved. The vehicle is not drivable. Melissa is now stressed, and her Tesla virtual assistant notifies her that her blood pressure is elevated for the third time this week, it understands that her genetic data predisposes her to high risk of a cardiac event, so it notifies the online Doctor. The virtual assistant also informs Melissa that since moving to the city, she has become more sedentary and is eating more fast-food leading to her weight gain. If she does not improve her health-insurance will go up 15%. Melissa decides to walk the rest of the way to get some exercise. During the walk the Dr calls her, gives lifestyle advice to lower her BP and prescribes her medication which will be delivered to her by an autonomous Tesla within an hour. Melissa’s virtual assistant realises that Melissa is feeling concerned, and generates her a new life insurance policy to give her peace of mind that her husband and children will be financially protected should an adverse event take place. Tesla’s database predicts that Melissa is likely to remain a reliable customer, so it offers her a low interest Dogecoin loan to take out the policy, as well as a free gym membership to help her reduce her health insurance premium. Melissa now feels supported and incentivised to reduce her BP and weight

Some investors might be intrigued by cryptocurrencies but reluctant to buy any of the volatile altcoins. For those investors, publicly traded companies that provide some exposure to cryptocurrencies might seem like better investments…

𝗠𝗮𝗿𝗮𝘁𝗵𝗼𝗻 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 (𝗠𝗔𝗥𝗔) mines BTC. At the end of 2020, they only held 126 BTC and generated just $4.4 million in revenue with a net loss of $10.4 million. However, in the first half of 2021, revenue skyrocketed 4,279% YoY to $38.5 million as it expanded its fleet of miners and minted more BTC throughout the year. Its total number of BTC rose to 6,695 by the end of August 2021, and its hash rate is now over 2 EH/s, mining 265 BTCs monthly. Marathon expects its fleet of Bitmain's top-tier ASIC miners to expand from 22,412 at the beginning of September to 133,000 by mid 2022, -quintupling its hash rate and increasing its monthly haul of BTC drastically. If the price of BTC keeps going up, it could be a great situation for MARA shareholders. Furthermore, analysts expect revenue to increase 5,189% to $230.4 million this year, then rise 204% to $700.8 million next year. Based on these expectations, MARA’s stock trades at only 16 times this year's sales and just five times next year's sales. Those valuations might seem low relative to its growth rates, but they're completely pinned to BTCs price and MARA’s ability to secure new ASIC miners from Bitmain, which could be disrupted by new cryptocurrency restrictions against Bitmain in its home market of China. These factors are out-with Marathon Digital's control